A randomised, double-blinded, placebo-controlled, pilot study of parenteral glutamine for allogeneic stem cell transplant patients

Supportive Care in Cancer

Volumn 13, Issue 10, 2005, Pages 790-796

  Blijlevens, N M A ^a   Donnelly, J P ^a   Naber, A H J ^a   Schattenberg, A V M B ^a   DePauw, B E ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALANYLGLUTAMINE; ALBUMIN; AMINOMIX; CITRULLINE; CYCLOPHOSPHAMIDE; GLUTAMINE; IDARUBICIN; PLACEBO; SUGAR;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GRAFT VERSUS HOST REACTION; HOSPITALIZATION; HUMAN; INFECTION; INTESTINE; IRRADIATION; MALE; MEMBRANE DAMAGE; MORTALITY; MUCOSA INFLAMMATION; PARENTERAL NUTRITION; PERMEABILITY BARRIER; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; DOUBLE-BLIND METHOD; FEMALE; GLUTAMINE; HUMANS; INFUSIONS, PARENTERAL; MALE; MIDDLE AGED; NETHERLANDS; PILOT PROJECTS; PLACEBOS; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 26244445238     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-005-0790-y     Document Type: Article

References (27)

1. Lacey JM, Wilmore DW (1990) Is glutamine a conditionally essential amino acid? Nutr Rev 48(8):297-309
2. Klimberg VS, McClellan JL, Organ CH Jr (1996) Honorary lectureship. Glutamine, cancer, and its therapy. Am J Surg 172(5):418-424
3. Ziegler TR (2001) Glutamine supplementation in cancer patients receiving bone marrow transplantation and high dose chemotherapy. J Nutr 131:2578S-2584S
4. Anderson PM, Ramsay NKC, Shu XO, Rydholm N, Rogosheske J, Nicklow R et al (1998) Effect of low-dose oral glutamine on painful stomatitis during bone marrow transplantation. Bone Marrow Transplant 22(4):339-344
5. Blijlevens NMA, Donnelly JP, De Pauw BE (2000) Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview. Bone Marrow Transplant 25:1269-1278
6. Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E, Rubenstein EB (2003) The burdens of cancer therapy: clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 98:1531-1539
7. Rapoport AP, Miller Watelet LF, Linder T, Rberly S, Raubertas RF, Lipp J et al (1999) Analysis of factors that correlate with mucositis in recipients of autologous and allogeneic stem-cell transplants. J Clin Oncol 17:2446-2453
8. Sonis ST, Oster G, Fuchs H, Bellm L, Bradford WZ, Edelsberg J et al (2001) Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol 19(8):2201-2205
9. Donnelly JP, Muus P, Schattenberg A, De Witte T, Horrevorts A, DePauw BE (1992) A scheme for daily monitoring of oral mucositis in allogeneic BMT recipients. Bone Marrow Transplant 9(6):409-413
10. Blijlevens NMA, van't Land B, Donnelly JP, M'Rabet L, DePauw BE (2004) Measuring mucosal damage induced by cytotoxic therapy. Support Care Cancer 12:227-233
11. Blijlevens NMA, Lutgens LCHW, Schattenberg AVMB, De Pauw BE (2004) Citrulline: a potentially simple quantitative marker of intestinal epithelial damage following myeloablative therapy. Bone Marrow Transplant 34(3):193-196
12. Schaap N, Schattenberg A, Bar B, Preijers F, Geurts van Kessel A, van der Maazen R et al (1997) Outcome of transplantation for standard-risk leukaemia with grafts depleted of lymphocytes after conditioning with an intensified regimen. Br J Haematol 98:750-759
13. Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16(1):31-41
14. Donnelly JP, Muus P, Schattenberg A, De Witte T, Horrevorts A, DePauw BE (1992) A scheme for daily monitoring of oral mucositis in allogeneic BMT recipients. Bone Marrow Transplant 9 (6):409-413
15. Jansen G, Muskiet FAJ, Schierbeek H, Berger R, Van melle G (1986) Capillary gas chromatographic profiling of urinary, plasma and erythrocyte sugars and polyols as their trimethylsilyl derivates, preceded by a simple and rapid prepurification method. Clin Chim Acta 157:277-294
16. Johnston JD, Harvey CJ, Menzies IS, Treacher DF (1996) Gastrointestinal permeability and absorptive capacity in sepsis. Crit Care Med 24:1144-1149
17. Lim SG, Menzies IS, Lee CA, Johnson MA, Pounder RE (1993) Intestinal permeability and function in patients infected with Human Immunodeficiency Virus: a comparison with Coeliac Disease. Scand J Gastroenterol 28:573-580
18. Pytlik R, Benes P, Patorkova M, Chocenska E, Gregora E, Prochazka B et al (2004) Standardized parenteral alanyl-glutamine dipeptide supplementation is not beneficial in autologous transplant patients: a randomized, double-blind, placebo controlled study. Bone Marrow Transplant 30:953-961
19. Lutgens LC, Blijlevens NM, Deutz NE, Donnelly JP, Lambin P, de Pauw BE (2005) Monitoring myeloablative therapy-induced small bowel toxicity by serum citrulline concentration: a comparison with sugar permeability tests. Cancer 103(1):191-199
20. Canovas G, Leon-Sanz M, Gomez P, Angeles Valero M, Gomis P, La Huerta JJ (2000) Oral glutamin supplements in autologous hematopoietic transplants: impact on gastro-intestinal toxicity and plasma protein levels. Haematologica 85(11):1229-1230
21. Piccirillo N, De Matteis S, Laurenti L, Chiusolo P, Sora F, Pittiruti M et al (2003) Glutamine-enriched parenteral nutrition after autologous peripheral blood stem cell transplantation: effects on immune reconstitution and mucositis. Haematologica 88(2):192-200
22. Ziegler TR, Young LS, Benfell K, Scheltinga M, Hortos K, Bye R et al (1992) Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study. Ann Intern Med 116(10):821-828
23. Schloerb PR, Amare M (1993) Total parenteral nutrition with glutamine in bone marrow transplantation and other clinical applications (a randomized, double-blind study) [see comments]. J Parenter Enter Nutr 17(5):407-413
24. Jonas CR, Puckett AB, Jones DP, Griffith DP, Szesycki EE, Bergman GF et al (2000) Plasma antioxidant status after high-dose chemotherapy: a randomized trial of parenteral nutrition in bone marrow transplantation patients. Am J Clin Nutr 72:181-189
25. Brown SA, Goringe A, Fegan C, Davies SV, Giddings J, Whittaker JA et al (1998) Parenteral glutamine protects hepatic function during bone marrow transplantation. Bone Marrow Transplant 22(3):281-284
26. Slaviero KA, Clarke SJ, Rivory LP (2003) Inflammatory response: an unrecognised source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapy. Lancet Oncol 4(4):224-232
27. Chen YL, Le V, Leneveu A, Dreyfus F, Stheneur A, Florentin I et al (1994) Acute-phase response, interleukin-6, and alteration of cyclosporine pharmacokinetics. Clin Pharmacol Ther 55 (6):649-660